Pilot study introducing a new EQA scheme for Mycobacterium tuberculosis drug resistance

The Finnish EQA provider Labquality has introduced a new External Quality Assessment (EQA) scheme for Mycobacterium tuberculosis, drug resistance, by performing a pilot study named Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection, in June 2022.